Kan. Stat. § 65-6b03
Current through 2024 Session Acts Chapter 111 and 2024 Special Session Acts Chapter 4
A physician may prescribe or administer amygdalin (laetrile) as an adjunct to recognized, customary or accepted modes of therapy or by itself in the treatment of any malignancy, disease, illness or physical condition of a patient who has signed the written informed request substantially as set forth in K.S.A. 65-6b05.
K.S.A. 65-6b03